NCLAT: Consideration of Debt Restructuring by Lenders Doesn’t Bar Member from Initiating Proceedings  ||  Delhi High Court: In Matters of Medical Evaluation, Courts Should Exercise Restraint  ||  Delhi HC: Any Person in India Has Right to Legally Import Goods from Abroad and Sell the Same  ||  Delhi HC: Waiver to Section 12(5) of Arbitration Act to be Given Once Tribunal is Constituted  ||  Supreme Court Has Asked States to Regularise Existing Court Managers  ||  SC: Union & States to Create Special POSCO Courts on Top Priority  ||  SC Upholds Authority of CERC to Award Compensation for Delays  ||  SC: Arbitral Tribunal Has Discretion to Include in Sum Awarded, Interest at Rate as it Deems Reasonab  ||  SC: Cannot Use Article 142 to Frame Guidelines on Judicial Recusal  ||  SC: Satisfaction Recorder in One EP Won’t Affect Subsequent EPs for Future Breaches    

SC Seeks Clarification on Risk and Cost of Manufacture of Covid Vaccines - (03 Jun 2021)

CIVIL

Supreme Court has sought clarification on whether it would be accurate to state that private entities had alone borne the risk and cost of manufacture, noting that the Centre had financed and facilitated the production of vaccines through concessions or otherwise. The Court has noted that as Emergency Use Authorisation had been granted by the Centre to the manufacturers thereby minimizing their risk, it should have factored in the pricing.

Tags : SUPREME COURT   COST OF MANUFACTURE OF COVID VACCINES  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved